Orchestra BioMed Holdings, Inc.OBIONASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+24.6%
5Y CAGR+20.0%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+24.6%/yr
Annual compound
5Y CAGR
+20.0%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$26.91M+12.5%
2024$23.93M+18.1%
2023$20.26M+45.5%
2022$13.92M+75.6%
2021$7.93M-26.8%
2020$10.83M-